scholarly journals DSM-5 Boom o esperanza

2013 ◽  
Vol 6 (1) ◽  
pp. 6-7
Author(s):  
Jorge Mauricio Cuartas Arias ◽  
Carlos López Jaramillo

After fourteen years of review, the expected update of the Diagnostic and Statistical Manual of Mental Disorders (DSM) has generated great controversy among psychiatrists and psychologists around the world. So far, it is known that the new version (DSM-5), officially presented for the first time in May 18 of this year as part of the annual meeting of the American Psychiatric Association (APA), will be available in Spanish language at the beginning of 2014. However, the reviews and comments for and against the new version suggest that there is no consensus in the scientific community to address mental illness. Beyond the instructive of categorical diagnosis that has prevailed in previous versions and a good part of the new text, the dimensional proposal is articulated with the use of clinical subtypes, severity levels and the inclusion of transverse symptoms, which allow to have a deterioration or

2019 ◽  
Vol 28 (8) ◽  
pp. 932-948 ◽  
Author(s):  
Melissa Roy ◽  
Marie-Pier Rivest ◽  
Dahlia Namian ◽  
Nicolas Moreau

Since its initial publication, the Diagnostic and Statistical Manual of Mental Disorders has been the object of criticism which has led to regular revisions by the American Psychiatric Association. This article analyses the debates that surrounded the publication of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Building on the concepts of public arenas and reception theory, it explores the meaning encoded in the manual by audiences. Our results, which draw from a thematic analysis of traditional and digital media sources, identify eight audiences that react to the American Psychiatric Association’s narrative of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.): conformist, reformist, humanist, culturalist, naturalist, conflictual, constructivist and utilitarian. While some of their claims present argumentative polarities, others overlap, thus challenging the idea, often presented in academic publications, of a fixed debate. In order to further discuss on the Diagnostic and Statistical Manual of Mental Disorders, we draw attention to claims that ‘travel’ across different communities of audiences.


2013 ◽  
Vol 37 (5) ◽  
pp. 171-174 ◽  
Author(s):  
Neil Krishan Aggarwal

SummaryIn July 2012, the American Psychiatric Association (APA) closed its final commenting period on draft criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), slated for publication in May 2013. DSM-5 raises familiar questions about the cultural assumptions of proposed diagnoses, the scientific evidence base of these criteria and their validity in international settings. I review these issues since the publication of DSM-IV. I assess the cultural validity of DSM-5 and suggest areas of improvement.


Author(s):  
Libi Shen

The birth of the Internet in 1969 has changed people's lives immensely in the past 48 years. Over the years, this invention has brought people connection, information, communication, business, entertainment, and so forth; however, researchers have found the impact of the Internet's byproduct, namely Internet addiction, in the past two decades as well. It was argued that Internet addiction might be detrimental to people's mental and physical health. The problem is that Internet addiction is not clearly defined, nor has it been included in Diagnostic and Statistical Manual for Mental Disorders (DSM-5) by American Psychiatric Association. If the definition is not clear and the symptoms are varied, the treatment for Internet addiction would become an issue. In this chapter, the researcher will focus on different approaches to the treatment of Internet addiction based on research after reviewing the definitions, theories, causes, consequences, and symptoms of Internet addiction.


2015 ◽  
Vol 17 (2) ◽  
pp. 109-124 ◽  
Author(s):  
Ester Holte Kofod

Grief is sometimes poetically described as the price of love: An inescapable existential condition of human life. However, throughout the 20th century, grief has increasingly come to be understood as a pathological condition that requires psychological and/or medical intervention. With the release ofDiagnostic and Statistical Manual of Mental Disorders(5th ed.,DSM-5; American Psychiatric Association, 2013), grief came close to being included as a separate mental disorder. However, the diagnostic revisions concerning bereavement have been met with criticism of medicalizing grief and of exceeding the territory of psychiatry beyond its legitimate borders. On this basis, I argue that grief is currently a border diagnosis, that is, a condition whose meanings are informed in heterogeneous ways by medical, psychiatric, and psychological understandings yet constantly challenged by alternative, nonmedicalizing discourses. Drawing on empirical findings from an ongoing interview study with bereaved parents after infant loss, I analyze and discuss 4 different accounts concerning the question of diagnosing grief: (a) diagnosis as a legitimating and normalizing practice, (b) diagnosis as a demarcation practice, (c) diagnosis as pathologization, and (d) diagnosis as a normative ideal. Through the examples, I attempt to demonstrate how bereaved individuals do not merely passively adopt but reflectively use these kinds of understandings to deal with their grief.


Diagnosis ◽  
2016 ◽  
Vol 3 (1) ◽  
pp. 9-12
Author(s):  
Kerry G. Baker

AbstractDespite differing target audiences and scope it is possible to compare the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington: American Psychiatric Association, 2013] and the Second International Working Group for New Research Criteria for the Diagnosis of Alzheimer’s Disease (IWG-2) [Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29] diagnostic criteria for both Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). With regard to the diagnosis of AD the principal difference is the inclusion of biomarkers in the IWG-2 diagnostic criteria for this condition. This creates a number of difficulties including a lack of regulatory approval, cultural and other objections to the collection of cerebrospinal fluid (CSF), and a lack of facilities for collection and analysis restricting analysis of CSF proteins to larger tertiary centres [Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014;13:614–29]. With regard to diagnostic criteria for DLB, IWG-2 research criteria designate the co-occurrence of AD and DLB as ‘mixed AD’. However, Alzheimer’s type pathology (ADTP) and Lewy body pathology frequently occur together rendering a separate ‘mixed AD’ category superfluous. The reality is that routine clinical diagnosis of AD and DLB will continue to be based on a thorough general and neurological examination indicating a preponderance of signs and symptoms for one or other of these conditions [Seeley WW, Miller BL. Alzheimer’s disease and other dementias. In: Hauser SL, Josephson SA, editors. Harrison’s neurology in clinical medicine, 3rd ed. New York: McGraw Hill, 2013]. Similarly, AD and DLB research will continue to primarily depend on clinically focussed DSM-5 criteria, making DSM-5 superior to IWG-2 in both clinical and research settings.


Author(s):  
Janet B. W. Williams ◽  
Michael First

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association is referred to as DSM-5™. DSM-5’s early predecessor, DSM-III, differed considerably from the first two editions. Its innovative incorporation of specified diagnostic criteria had a major impact on the field of mental health. In DSM-5, these criteria have been further updated to reflect the important gains in our understanding of mental disorders.


2018 ◽  
Vol 31 (2) ◽  
pp. e000012
Author(s):  
Balaswamy Reddy ◽  
Soumitra Das ◽  
Srinivas Guruprasad

There is some evidence consistently linking the occurrence of de novo obsessive-compulsive disorder (OCD) with clozapine. This skin-picking disorder is also known as impulsive-compulsive disorder-unspecified which with an increasing convergence with OCD has been placed in the current Diagnostic and statistical manual of mental disorders-fifth edition by American Psychiatric Association (DSM-5), in the category of the obsessive-compulsive and related disorders. To the best of our knowledge, there is no literature relating antipsychotics like clozapine with the occurrence of skin-picking behaviour. In this article, we present a case in whom skin-picking behaviour emerged during the upward dose titration of clozapine and was successfully treated with escitalopram.


CNS Spectrums ◽  
2017 ◽  
Vol 22 (2) ◽  
pp. 155-160 ◽  
Author(s):  
Trisha Suppes ◽  
Michael Ostacher

For the first time in 20 years, the American Psychiatric Association (APA) updated the psychiatric diagnostic system for mood disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Perhaps one of the most notable changes in the DSM-5 was the recognition of the possibility of mixed symptoms in major depression and related disorders (MDD). While MDD and bipolar and related disorders are now represented by 2 distinct chapters, the addition of a mixed features specifier to MDD represents a structural bridge between bipolar and major depression disorders, and formally recognizes the possibility of a mix of hypomania and depressive symptoms in someone who has never experienced discrete episodes of hypomania or mania. This article reviews historical perspectives on “mixed states” and the recent literature, which proposes a range of approaches to understanding “mixity.” We discuss which symptoms were considered for inclusion in the mixed features specifier and which symptoms were excluded. The assumption that mixed symptoms in MDD necessarily predict a future bipolar course in patients with MDD is reviewed. Treatment for patients in a MDD episode with mixed features is critically considered, as are suggestions for future study. Finally, the premise that mood disorders are necessarily a spectrum or a gradient of severity progressing in a linear manner is argued.


Author(s):  
Ειρήνη Μούτσου ◽  
Ευγενία Γεωργάκα

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM- 5) was released by the American Psychiatric Association in May 2013 and has provoked a broad scientific discussion, since it entails significant changes in relation to its previous editions. The current paper offers a review of this discussion, with emphasis on the main changes that are under dispute. Initially, we discuss the developmental course of the various editions of the DSM, the main principles and practices of the current edition as well as the main points of critique against it. We then examine in more detail some significant changes in particular diagnostic categories and their expected implications for the diagnosis and treatment of these mental disorders. In conclusion, the main critique against DSM-5 is that it seems to intensify the medicalisation of mental disorders, which characterises its latest editions, to pathologise a range of everyday experiences and behaviours, and to broaden the diagnosed population, especially to children and the elderly, expanding possibly the use of medication to new age groups.


2015 ◽  
Vol 22 (2) ◽  
pp. 127-133 ◽  
Author(s):  
Mohammad A. Aboul-ata ◽  
Fatma A. Amin

Objective: In the present study, we created a new valid rating scale to estimate the prevalence of ADHD among school-age children in Fayoum City. Method: We conducted two consequential studies (Studies 1 and 2). In Study 1, the sample comprised 106 children. The ages of the sample participants ranged between 6 and 14 years. The purpose of that study was to validate a new Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5)-based ADHD rating scale. In Study 2, the sample consisted of 420 children with ages ranging from 6 to 14 years. We used the new rating scale to estimate the prevalence of ADHD. Results: The first study showed that the new rating scale for ADHD was valid. The second study revealed that the prevalence of ADHD in Fayoum City was 20.5%, with 33.8% among boys and 6.8% among girls. Conclusion: We validated a new ADHD rating scale and estimated the prevalence of ADHD in Fayoum City for the first time in Egypt.


Sign in / Sign up

Export Citation Format

Share Document